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THE EFFECT OF LOCAL ANAESTHETIC WOUND INFILTRATION ON
CHRONIC PAIN AFTER TOTAL HIP REPLACEMENT: A RANDOMISED
CONTROLLED TRIAL
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Purpose: Most patients who have hip replacement do so to relieve pain
and stiffness associated with osteoarthritis. However, around 10% of
patients who have total hip replacement report chronic pain related to
their operated joint 3 months after surgery. It is important to identify
ways to reduce the chance that patients will have this type of ongoing
pain. A known risk factor for chronic post-surgical pain is the severity of
acute post-operative pain. There is evidence that local anaesthetic
wound inﬁltration reduces acute post-operative pain; however, it is
uncertain whether it is also effective at reducing chronic pain in the
long-term. The aim of this randomised controlled trial (RCT) was to
determine if local anaesthetic wound inﬁltration could signiﬁcantly
reduce the severity of joint pain at 12-months after total hip
replacement.
Methods: This study was a double-blind randomised controlled trial of
patients undergoing primary total hip replacement for osteoarthritis at
a high volume elective orthopaedic centre in the UK. Patients were
randomised to receive additional intra-operative local anaesthetic
wound inﬁltration or the standard anaesthesia regimen alone. The
usual anaesthesia regimen consisted of spinal or general anaesthetic,
depending on patient clinical factors. Patients in the intervention group
received an added injection of 60 mls of 0.25% bupivacaine with 1 in
200,000 adrenaline at the wound site before surgical closure. Post-
operative pain management was the same for the intervention and
usual care group, and included a patient-controlled analgesia device.
Randomisation was minimised by baseline hip pain severity and sur-
gical approach. The primary outcome was pain at 12-months post-
operative measured by the WOMAC Pain scale. Secondary outcomes
included the WOMAC Function and Stiffness scales, the Intermittent
and Constant Osteoarthritis Pain (ICOAP) measure and the PainDETECT
(a measure of neuropathic pain), collected by postal questionnaires
administered at 3-months, 6-months and 12-months after surgery.
Measurements of daily acute post-operative pain severity were col-
lected on post-operative days 1-3 using a visual analogue scale. Com-
plications and adverse events were collected from patients’ self-report
at 3-months and 12-months and a review of medical records. WOMAC
Pain scores at 12-months post-operative were categorised into “No
pain”; “Mild”; “Moderate” and “Severe” and analyzed using generalized
ordered logit models in an intent-to-treat approach. Results are pre-
sented as odds ratios and 95% conﬁdence intervals (CIs). Secondary
outcomes were analysed using generalised linear models and general-
ized linear mixed models.
Results: 639 eligible patients were approached to take part in this study
and 322 consented to participate (50% recruitment rate). Prior to sur-
gery, 163 patients were randomised to the intervention group and 159
to the standard care group. Patients receiving additional local anaes-
thetic wound inﬁltration were less likely to report severe pain at 12-
months post-operative compared with patients receiving the usual
anaesthetic regimen alone (OR¼0.13; 95% CIs¼0.03, 0.62; p¼0.011). At
12-months post-operative, patients in the intervention group were also
less likely to report neuropathic pain on the PainDETECT questionnaire
(OR¼0.22; 95% CIs¼0.05, 0.97; p¼0.046). No differences were observed
for outcomes assessed through ICOAP, WOMAC function or WOMAC
stiffness questionnaires. During their inpatient stay, patients of both
groups reported comparable levels of daily pain, with the exception of
pain on the second post-operative night (Coef.¼ -0.83; 95% CIs -1.41,
-0.26; p¼0.005). Complications and adverse events were similar
between the intervention and standard care groups.
Conclusions: This is the ﬁrst RCT to assess the longer-term effects of a
local anaesthetic wound inﬁltration on pain severity after hip replace-
ment. We found that local anaesthetic wound inﬁltration administered
before wound closure is effective in reducing the number of patients
experiencing severe pain at 12-months after hip replacement. There
was also some evidence of reductions in neuropathic pain at 12-monthspost-operative and pain on the second post-operative night for patients
in the intervention group compared with the usual care group. We
recommend the addition of local anaesthetic wound inﬁltration to the
usual anaesthesia regimen during primary total hip replacement sur-
gery to reduce the risk of severe chronic pain after surgery.
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EFFECTIVENESS OF EXERCISE THERAPY ADDED TO GENERAL
PRACTITIONERS’ CARE VERSUS GENERAL PRACTITIONERS’ CARE
ALONE IN PATIENTS WITH HIP OSTEOARTHRITIS
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Purpose: The main goal of this comparative study was to investigate
whether exercise therapy added to general practitioners’ care is effec-
tive compared to general practitioners’ care only in patients with a new
episode of hip OA in general practice, over a period of 12 months.
Methods: Study design used was a randomized controlled trial with a
parallel group design. Patients could participate the trial if they were 45
years or older, comply with the clinical American College of Rheuma-
tology criteria for hip OA, and visited their general practitioner for a new
episode of complaints due to hip osteoarthritis. Patients were excluded
if they: 1) were already treated with exercise therapy in the present
episode of hip OA, 2) had a hip pain score of<2 on the 11-point numeric
rating scale (0 to 10), 3) had a high level of physical function, a score of
<2 on the walking ability and the physical function sections of the
Algofunctional index, 4) had undergone hip surgery or those on the
waiting list for surgery, 5) had severe disabling co-morbidity and 6) had
insufﬁcient comprehension of the Dutch language and/or were men-
tally incapable of participation. The patients were randomized using
sealed envelopes based on a computer generated random table in two
treatment groups: one group received exercise therapy supervised by a
physiotherapist added to general practitioners’ care and the control
group received general practitioners’ care only. The exercise therapy
consisted of up to 15 sessions in the ﬁrst threemonths and three follow-
up (booster)sessions in month ﬁve, seven and nine. The primary out-
comesmeasured for the clinical studywere severity of hip pain and hip-
related function measured with the Hip disability Osteoarthritis Out-
come Score (HOOS). Secondary outcome measures were: severity of hip
pain averaged over past week measured with an 11-point numerical
rating scale, severity of intermittent and constant hip pain measured
with the Intermittent and Constant Osteoarthritis Pain (ICOAP) ques-
tionnaire, functional mobility measure with the timed Up and Go test,
patients’ perceived recovery measured with a 7-point Likert scale,
quality of life measuredwith the EQ-5D instrument. The patients scored
the outcomes using questionnaires at 6 weeks and at 3, 6, 9 and 12
months after baseline measurement. All analyses were performed
according to intention to treat principle. We used linear mixed models
analysis with repeated measurements and adjusted the analysis for age
and body mass index.
Results: The study took place in the period 2009-2012 and 203 patients
from 101 general practitioners participated. The mean age was 65 years
and there were slightly more women (60%) than men. Randomly allo-
cated to the exercise group were 101 patients and 102 patients to the
group that received general practitioners’ care only. At baseline both
groups were quite similar, however, the number of patients who
reported performing unsupervised hip exercises prior to baseline was
15% higher in the control group. In addition, the number of patients
reporting using pain medication daily prior to baseline was 10% higher
in the control group. Therefore, besides age and body mass index,
analyses were also adjusted for these two variables. Regarding com-
pliance: 97 (96%) of the patients in the exercise group had visited a
physiotherapist. Mean number of visits was 9 (SD 4.0). Forty-eight
patients (48%) had 1 booster session, 46 (46%) 2 booster sessions and 36
(36%) received all three prescribed booster sessions. In the control
group, 14 (14%) patients had visited a physiotherapist (mean visits: 8;
SD 6.2). At 3 months follow-up there were statistically signiﬁcant and
clinically relevant differences between the groups on the primary
outcomes HOOS pain -3.9 (95%CI -7.7;-0.1: p-value of 0.04) and HOOS
function -5.2 (95%CI -9.1;-1.2: p-value of 0.01) in favor of the patients
who received the exercise therapy. However, this effect was no longer
present after 12 months follow-up. The analyses showed the same for
